Skip to main content

Advertisement

Log in

Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We encountered a patient with previously well-controlled Wilson disease who experienced fulminant hepatic failure with hemolytic anemia, possibly caused by the dietary supplement Health Proportion® (Jubilant Co., Ltd., Ehime, Japan). A 21-year-old woman was admitted to our hospital with marked liver dysfunction and severe hemolytic anemia. Free serum copper level was elevated at 101 μg/dl, and urinary copper excretion was extremely increased (25,600 μg/day). Plasma exchange and continuous hemodiafiltration were performed to remove serum copper and to treat the hemolytic anemia. However, liver function did not improve, and she underwent liver transplantation on 28th day after admission. Copper and iron contents in the resected liver were high at 851.9 μg and 551.7 μg/dry liver weight (g), respectively, despite the patient having regularly taken d-penicillamine since diagnosis and having a well-controlled copper level 1 year before her admission. Two months before admission, the patient had taken a dietary supplement made from soybeans for 1 month. This supplement was labeled as containing large amounts of copper and iron, and we assume that this caused fulminant hepatic failure with hemolytic crisis in this patient. It is important to be mindful of the micronutrient content of dietary supplements, especially for metabolic disorder patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34:295–507.

    Article  Google Scholar 

  2. Kusuda Y, Hamaguchi K, Mori T. Novel mutations of the ATP7B gene in Japanese patients with Wilson disease. J Hum Genet. 2000;45:86–91.

    Article  CAS  PubMed  Google Scholar 

  3. Ferenci P, Członkowska A, Merle U, Ferenc S, Gromadzka G, Yurdaydin C, et al. Late-onset Wilson’s disease. Gastroenterology. 2007;132:1294–8.

    Article  CAS  PubMed  Google Scholar 

  4. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003;37:1475–92.

    Article  PubMed  Google Scholar 

  5. Frydman M. Genetic aspects of Wilson’s disease. J Gastroenterol Hepatol. 1990;5:483–90.

    Article  CAS  PubMed  Google Scholar 

  6. Thomas GR, Forbes JR, Roberts EA. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet. 1995;9:210–7.

    Article  CAS  PubMed  Google Scholar 

  7. McIntyre N, Clink HM, Levi AJ. Hemolytic anemia in Wilson’s disease. New Engl J Med. 1967;276:439–44.

    Article  CAS  PubMed  Google Scholar 

  8. Shiono Y, Kumasawa S, Hayashi H. Iron accumulation in the liver of male patients with Wilson’s disease. Am J Gastroenterol. 2001;96:3147–51.

    Article  CAS  PubMed  Google Scholar 

  9. Rakela J, Kurtz SB, McCarthy JT. Fulminant Wilson’s disease treated with postdilution hemodiafiltration and orthotopic liver transplantation. Gastroenterology. 1986;90:2004–7.

    Article  CAS  PubMed  Google Scholar 

  10. Sarles J, Lefevre P, Picon G. Plasma exchange for fulminant Wilson disease. Eur J Pediatr. 1992;151:310.

    Article  CAS  PubMed  Google Scholar 

  11. Kiss JE, Berman D, Van Thiel D. Effective removal of copper by plasma exchange in fulminant Wilson disease. Transfusion. 1998;38:327–31.

    Article  CAS  PubMed  Google Scholar 

  12. Nagata Y, Uto H, Hasuike S, Ido A, Hayashi K, Eto T, et al. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation for acute fulminant Wilson disease. Intern Med J. 2003;42:967–70.

    Article  Google Scholar 

  13. Shinno H, Sugita Y, Wada M. Foods with health claims. Shokuseikatsu. 2004;98:47–52.

    Google Scholar 

  14. Ogimoto M, Uematsu Y, Kabashima J, Suzuki K, Yasuno T, Kohmaru Y, et al. Determination of mineral contents in commercial mineral supplements, vol 57. Tokyo: Annual report of Tokyo Metropolitan Institute of Public Health; 2006. p. 267–71.

    Google Scholar 

  15. Dietary reference intakes for Japanese. Tokyo: Ministry of Health, Labour, and Welfare, Japan; 2005.

  16. Turnlund JR. Human whole-body copper metabolism. Am J Clin Nutr. 1998;67(suppl):960S–4S.

    CAS  PubMed  Google Scholar 

  17. Walshe JM, Yealland M. Chelation treatment of neurological Wilson’s disease. Q J Med. 1993;86:197.

    CAS  PubMed  Google Scholar 

  18. Watanabe M, Shibuya A. Validity study of a new diagnostic scale for drug-induced liver injury in Japan—comparison with two previous scales. Hepatol Res. 2004;30:148–54.

    Article  CAS  PubMed  Google Scholar 

  19. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664–9.

    Article  CAS  PubMed  Google Scholar 

  20. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int. 2007;27:465–74.

    Article  PubMed  Google Scholar 

  21. Whitt KN, Ward SC, Deniz K, Liu L, Odin JA, Qin L. Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis. 2008;28:226–31.

    Article  CAS  PubMed  Google Scholar 

  22. Kawata K, Takehira Y, Kobayashi Y, Kitagawa M, Yamada M, Hanajima K, et al. Three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement for weight loss. Intern Med. 2003;42:1188–92.

    Article  PubMed  Google Scholar 

  23. Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc. 2006;81:541–4.

    Article  PubMed  Google Scholar 

  24. Koga H, Taguchi J, Ishii K, Inoue K, Sato K, Sanefuji T. A survival case of fulminant hepatic failure caused by Chinese diet medicine (in Japanese with English abstract). Kanzo. 2003;44:117–22.

    Article  Google Scholar 

  25. Food composition database (Internet). Japan Science and Technology Agency (updated 2005 May 31). Available from: http://fooddb.jp/.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terumi Takahara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawai, K., Atarashi, Y., Takahara, T. et al. Dietary supplement implicated in fulminant hepatic failure in a well-controlled Wilson disease patient. Clin J Gastroenterol 2, 119–124 (2009). https://doi.org/10.1007/s12328-008-0056-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-008-0056-6

Keywords

Navigation